GSK has upgraded its longstanding alliance ... that it has signed a non-binding memorandum of understanding with South Africa-based Afrigen Biologics to support the development of an mRNA vaccine ...

The Nigerian economy has seen the closure of many companies, especially multinational firms, which threw many Nigerians into ...

The continent is being drenched in an avalanche of medical disinformation with the aim of undermining western influence ...

and South Africa, with a readout expected in 2025. Meanwhile, some research has found that vaccines against N. meningitidis, designed to protect against meningitis – including GSK’s MenB shot ...

South African grocery retailer Pick n Pay has decided to leave Nigeria, less than five years after it announced with ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Shalini Kumar has joined Kenvue as Head - Consumer Experience. Shalini was earlier with Halenon as Area Media Lead for ...

GSK's share price surged 6% yesterday in the biggest rise seen since December 2022, after the company settled 93% of cases related to the Zantac litigation. The settlement will be reflected in Q3 ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the May 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time ...